Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Short-Term Debt issuances (2020)

Sunshine Biopharma's Short-Term Debt issuances history spans 1 years, with the latest figure at $33607.0 for Q4 2020.

  • For Q4 2020, Short-Term Debt issuances changed N/A year-over-year to $33607.0; the TTM value through Dec 2021 reached $36607.0, changed N/A, while the annual FY2021 figure was $61500.0, 51.45% up from the prior year.
  • Short-Term Debt issuances reached $33607.0 in Q4 2020 per SBFM's latest filing, up from $3000.0 in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $33607.0 in Q4 2020 to a low of $3000.0 in Q3 2020.